148 related articles for article (PubMed ID: 27007970)
21. Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
Peterlin P; Garnier A; Tissot A; Garandeau C; Houreau-Langlard D; Hourmant M; Vantyghem S; Bonnet A; Guillaume T; Béné MC; Le Gouill S; Moreau P; Chevallier P
Ann Hematol; 2016 Oct; 95(10):1737-8. PubMed ID: 27465153
[No Abstract] [Full Text] [Related]
22. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
23. Extramedullary disease in APL: a real phenomenon to contend with or not?
Ganzel C; Douer D
Best Pract Res Clin Haematol; 2014 Mar; 27(1):63-8. PubMed ID: 24907018
[TBL] [Abstract][Full Text] [Related]
24. Retinoic acid plus arsenic trioxide, the ultimate panacea for acute promyelocytic leukemia?
Lallemand-Breitenbach V; de Thé H
Blood; 2013 Sep; 122(12):2008-10. PubMed ID: 23894153
[TBL] [Abstract][Full Text] [Related]
25. ATRA + ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia?
Breccia M; Cicconi L; Lo-Coco F
Curr Opin Hematol; 2014 Mar; 21(2):95-101. PubMed ID: 24434605
[TBL] [Abstract][Full Text] [Related]
26. Treatment of therapy related acute promyelocytic leukemia with the combination of all trans retinoic acid and arsenic trioxide without chemotherapy: a series of three patients.
Malhotra P; Varma N; Arora N; Das R; Nath A; Patel FD; Varma S
Leuk Lymphoma; 2010 May; 51(5):933-6. PubMed ID: 20350274
[No Abstract] [Full Text] [Related]
27. Current treatment of acute promyelocytic leukemia.
Lo Coco F; Ammatuna E; Sanz MA
Haematologica; 2007 Mar; 92(3):289-91. PubMed ID: 17339175
[No Abstract] [Full Text] [Related]
28. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
[TBL] [Abstract][Full Text] [Related]
29. Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old child.
Rock N; Mattiello V; Judas C; Huezo-Diaz P; Bourquin JP; Gumy-Pause F; Ansari M
Pediatr Hematol Oncol; 2014 Mar; 31(2):143-8. PubMed ID: 24498972
[TBL] [Abstract][Full Text] [Related]
30. The expanding role of arsenic in acute promyelocytic leukemia.
Tallman MS
Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
[TBL] [Abstract][Full Text] [Related]
31. Complete remission of acute promyelocytic leukemia in a very elderly patient after treatment with low dose arsenic trioxide and sequential retinoic acid: a case report.
Lin J; Zhu H; Li S; Fan H; Lu X
Ann Hematol; 2014 Feb; 93(2):335-6. PubMed ID: 23719691
[No Abstract] [Full Text] [Related]
32. Oral arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
Au WY; Kumana CR; Kou M; Mak R; Chan GC; Lam CW; Kwong YL
Blood; 2003 Jul; 102(1):407-8. PubMed ID: 12814916
[No Abstract] [Full Text] [Related]
33. Bruising and abnormal leucocytes on a blood film--a haematological emergency.
Chavda SJ; Lindsay S; Willis F; Koh M
BMJ; 2017 Mar; 356():j1164. PubMed ID: 28336583
[No Abstract] [Full Text] [Related]
34. Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.
Huang H; Qin Y; Xu R; You X; Teng R; Yang L; Xu M; Liu H
Leuk Res; 2012 Jul; 36(7):841-5. PubMed ID: 22534100
[TBL] [Abstract][Full Text] [Related]
35. [All-trans retinoic acid and arsenic trioxide: their molecular mechanisms of action and updated clinical progress in APL therapy].
Shinagawa K
Rinsho Ketsueki; 2011 Jul; 52(7):469-83. PubMed ID: 21821978
[No Abstract] [Full Text] [Related]
36. High efficacy of arsenic trioxide plus all-trans retinoic acid based induction and maintenance therapy in newly diagnosed acute promyelocytic leukemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Leuk Res; 2013 Jan; 37(1):37-42. PubMed ID: 23017225
[TBL] [Abstract][Full Text] [Related]
37. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
[TBL] [Abstract][Full Text] [Related]
38. Upfront maintenance therapy with arsenic trioxide in acute promyelocytic leukemia provides no benefit for non-t(15;17) subtype.
Chiang YH; Chang YF; Hsieh RK; Lin J; Chen CG; Lim KH; Lin HC; Chang MC
Asia Pac J Clin Oncol; 2012 Dec; 8(4):330-6. PubMed ID: 22897350
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide for the treatment of a relapsed acute promyelocytic leukemia with acute renal failure.
Yoon HS; Park TS; Jeong KH
Pediatr Blood Cancer; 2011 Dec; 57(6):1085. PubMed ID: 21656902
[No Abstract] [Full Text] [Related]
40. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]